Searched for
AKUMS DRUGS AND PHARMACEUTICAL
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Buy Akums Drugs & Pharmaceuticals, target price Rs 710: ICICI SecuritiesICICI Securities maintains a Buy call on Akums Drugs & Pharmaceuticals, setting a target price of Rs 710. The company reported a consolidat...
- Buy Akums Drugs & Pharmaceuticals, target price Rs 710: ICICI SecuritiesICICI Securities has given a buy call for Akums Drugs & Pharmaceuticals with a target price of Rs 710, citing profitable growth potential. ...
- Akums enters into Rs 1750 crore contract to supply pharma products to EuropeAkums Drugs & Pharmaceuticals has signed a long-term contract worth Rs 1760 crore with an unnamed global pharmaceutical company to manufact...
- Akums Drugs adj. net profit rises 16% YoY to Rs 66.7 crore in Q2FY25Akums Drugs and Pharmaceutical, a Delhi-based company, reported a 16% rise in profits compared to the same period last year. The company ac...
- Akum Drugs shares tumble 5% despite posting Rs 60 crore Q1 profitAkum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June...
- Akums Drugs and Pharma shares jump 8% post listing. Should you buy, sell or hold?Akums Drugs and Pharmaceuticals saw its shares rise 8% to Rs 784.6 on its debut, despite a strong subscription rate of 63.44 times. Analyst...
- Akums Drugs and Pharma shares list at 7% premium over issue priceAkums Drugs and Pharmaceuticals' shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subsc...
- Akums Drugs and Pharma shares to list on Tuesday. Here's what GMP suggestsAkums Drugs and Pharmaceuticals will debut on Tuesday. The stock, with a GMP of Rs 140, is expected to list at a 21% premium over the upper...
- Akums Drugs & Pharma IPO share allotment to be finalised today: Check status, GMP, listing date and other detailsAkums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...
- Akums Drugs and Pharma IPO: Check subscription on Day 3, GMP and other detailsNon-institutional investors subscribed 22.8 times, followed by retail investors, whose category was booked 13.8 times. The part reserved fo...
- Akums Drugs and Pharma IPO: Check subscription on Day 2, GMP and other detailsIn the unlisted market, shares of the company are currently commanding a premium of 26% over the IPO price, with GMP of Rs 175. The IPO its...
- Akums Drugs and Pharma IPO opens for subscription. Should you bid?Akums Drugs IPO Review GMP, Subs: Akums Drugs and Pharmaceuticals' IPO, valued at Rs 1,857 crore, closed on August 1. The issue included Rs...
- Akums Drugs and Pharma IPO opens tomorrow: Price band, GMP among 10 things to know before subscribingAkums Drugs and Pharma's IPO, open from July 30 to August 1, targets raising Rs 1857 crore. The company specializes in pharmaceutical devel...
- Akums Drugs and Pharmaceuticals Rs 1,857 crore IPO opens Tuesday. Check price band, other detailsAkums Drugs and Pharmaceuticals' Rs 1,857 crore IPO opened from July 30 to August 1, featuring a Rs 680 crore fresh issue and 1.73 crore sh...
- Akums gets DCGI nod for triple combination diabetes medicationAkums Drugs and Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) for a triple combination diabetes me...
- Akums Drugs & Pharmaceuticals forays into gummies segment, sets up manufacturing plant"We are always committed to ensuring that we do not just produce medicines that are effective, but also produce them in formats that are ea...
- Akums enters into a pact with Leiutis, Biophore for bringing therapeutics to IndiaThis association is set to bring succour in therapy areas of CNS disorders, pain management, and hormonal disorders, where there is a gap i...
- HC grants relief to Troikaa in patent case; restrains two firms from selling Dynapar injectionsHC has granted a temporary relief to Troikaa restraining two pharma companies from making & selling the patented versions of diclofenac inj...
Load More
